[ALA] QoQ Quarter Result on 30-Sep-2012 [#Q1]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
29-Sep-2012
Financial Year
2013
Quarter
30-Sep-2012 [#Q1]
Profit Trend
QoQ-
YoY-
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Revenue 1,256 3,121 3,121 985 985 1,048 1,048 12.84%
PBT -955 -166 -166 -438 -438 -483 -483 57.59%
Tax 90 0 0 87 87 0 0 -
NP -860 -166 -166 -351 -351 -483 -483 46.95%
Tax Rate - - - - - - - -
Total Cost 2,116 3,287 3,287 1,335 1,335 1,531 1,531 24.10%
Ratio Analysis
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
NP Margin -68.49 -5.32 -5.32 -35.61 -35.61 -46.09 -46.09 30.25%
Per Share
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
EPS -0.03 -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 31.06%
EPS Diluted -0.03 -0.00 -0.00 -0.01 -0.01 -0.02 -0.02 31.06%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.